Weil is representing American Securities in its definitive agreement to sell Paragon Medical, a global industry leader in highly engineered medical components and instruments, to AMETEK, Inc., a leading global provider of industrial technology solutions, in an all-cash transaction valued at approximately $1.9 billion. The transaction is subject to customary closing conditions, including applicable regulatory approvals. 

Based in New York with an office in Shanghai, American Securities is a leading U.S. private equity firm that invests in market-leading North American companies with annual revenues generally ranging from $200 million to $2 billion. American Securities and its affiliates have more than $27 billion under management.

The Weil team advising American Securities and Paragon Medical is led by Global Private Equity Co-Head Doug Warner and Private Equity partner Ryan Taylor, as well as Private Equity partner Jenna McBain and associates Sam de Blecourt, Caitlin Haefner and Andrew Distell. The team also includes Banking & Finance Co-Head Andrew Colao and associates Kaitlin Bond, Christina Ramos and Virginia Gordon; Tax partner Mark Hoenig and associate Natalia Pierotti; Executive Compensation & Benefits Head Paul Wessel and associate Radhika Tahiliani; Antitrust partners Megan Granger and Niklas Maydell and associates Steffen Giolda, Dan Nobil and Joon Cho; Regulatory Transactions Group Head Annemargaret Connolly and counsel Matthew Morton; and Regulatory Transaction Group partners Timothy Welch and John O’Loughlin and counsel Nathan Cunningham.